Eltrombopag-13C4 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

As an agonist of the Thrombopoietin (Tpo) receptor, Eltrombopag-13C4 can be used as treatment for thrombocytopenia

Eltrombopag-13C4 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Eltrombopag-13C4 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Shanghai Hongye Biotechnology Co. Ltd	400-9205774	sales@glpbio.cn	China	6777	58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.	18818260767	sales@chemegen.com	China	11218	58
Shenzhen ruikai de biotechnology co., ltd.	0755-61348847 17820674378	2682116078@qq.com	China	7843	58
Nanjing Shizhou Biology Technology Co.,Ltd	17301488900	judy.xia@synzest.com	China	12582	58
TLC Pharmaceutical Standards Ltd.	18012923235	chinasales04@tlcstandards.com.cn	China	4926	58

---

• Eltrombopag-13C4
• 3'-[2-[(2Z)-1-(3,4-DiMethylphenyl)-1,5-dihydro-3-Methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid-13C4
• SB 497115-13C4
• C2113C4H22N4O4
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals
• Agonist
• Aromatics
• Heterocycles